HK1093729A1 - Substituted quinolones - Google Patents

Substituted quinolones

Info

Publication number
HK1093729A1
HK1093729A1 HK07110374A HK07110374A HK1093729A1 HK 1093729 A1 HK1093729 A1 HK 1093729A1 HK 07110374 A HK07110374 A HK 07110374A HK 07110374 A HK07110374 A HK 07110374A HK 1093729 A1 HK1093729 A1 HK 1093729A1
Authority
HK
Hong Kong
Prior art keywords
substituted quinolones
quinolones
substituted
prophylaxis
medicaments
Prior art date
Application number
HK07110374A
Other languages
English (en)
Inventor
Schohe-Loop Rudolf
Zimmermann Holger
Henninger Kerstin
Paulsen Daniela
Roille Thomas
Lang Dieter
Thede Kai
Fuerstner Chantal
Brueckner David
Koibberling Johannes
Bauser Marcus
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of HK1093729A1 publication Critical patent/HK1093729A1/xx
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Dental Preparations (AREA)
HK07110374A 2004-07-21 2007-09-24 Substituted quinolones HK1093729A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004035203A DE102004035203A1 (de) 2004-07-21 2004-07-21 Substituierte Chinolone
PCT/EP2005/007601 WO2006008046A1 (de) 2004-07-21 2005-07-13 Substituierte chinolone

Publications (1)

Publication Number Publication Date
HK1093729A1 true HK1093729A1 (en) 2007-03-09

Family

ID=34993318

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07110374A HK1093729A1 (en) 2004-07-21 2007-09-24 Substituted quinolones

Country Status (10)

Country Link
US (1) US7867992B2 (es)
EP (1) EP1768973B1 (es)
JP (1) JP5068648B2 (es)
CN (1) CN101031557B (es)
AT (1) ATE380188T1 (es)
CA (1) CA2574464C (es)
DE (2) DE102004035203A1 (es)
ES (1) ES2296205T3 (es)
HK (1) HK1093729A1 (es)
WO (1) WO2006008046A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456083C (en) * 2001-08-03 2012-05-01 John K. Inman Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
US7605289B2 (en) * 2005-06-17 2009-10-20 Amgen, Inc. Benzamide derivatives and uses related thereto
DE102005030524A1 (de) * 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituierte Chinolone II
US7893299B2 (en) * 2005-07-21 2011-02-22 Nereus Pharmaceuticals, Inc. Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators
DE102006005861A1 (de) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
KR20090061029A (ko) * 2006-10-06 2009-06-15 보오슈 앤드 롬 인코포레이팃드 퀴놀론 카르복실산, 그의 유도체, 그의 제조 방법 및 항박테리아제로서의 그의 용도
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
CN103524492A (zh) * 2013-10-23 2014-01-22 中国药科大学 侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
WO2015104422A1 (en) 2014-01-13 2015-07-16 Basf Se Dihydrothiophene compounds for controlling invertebrate pests

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932487A (en) 1960-07-25 1963-07-31 D G Searle & Co Piperidine derivatives
DE3420743A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
CN1019114B (zh) 1986-03-31 1992-11-18 三共株式会社 喹啉-3-羟酸衍生物的制备方法
DE3702393A1 (de) 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
AU618823B2 (en) 1988-07-20 1992-01-09 Sankyo Company Limited 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
US4959363A (en) 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
DE4303657A1 (de) 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR960004339A (ko) 1994-07-02 1996-02-23 임성기 신규한 퀴놀린계 화합물 및 그 의 제조방법
MX9800921A (es) 1995-08-02 1998-05-31 Chirotech Technology Ltd Quinolonas y su uso terapeutico.
WO1997004779A1 (en) * 1995-08-02 1997-02-13 Chiroscience Limited Quinolones and their therapeutic use
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
DE19937024A1 (de) 1999-08-05 2001-02-08 Bayer Ag Verwendung von Acylsulfonamido substituierten Polymethin-Farbstoffen als Fluoreszenz-Farbstoffe und/oder Marker
AU2001280091A1 (en) 2000-08-01 2002-02-13 Wockhardt Limited Inhibitors of cellular efflux pumps of microbes
GB0023918D0 (en) 2000-09-29 2000-11-15 King S College London Antiparasitic compounds
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
DE10138578A1 (de) * 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2005511743A (ja) 2001-12-13 2005-04-28 ウォックハート・リミテッド 新世代の三重標的化したキラルな広域スペクトラム抗菌性の７位置換ピペリジノ−キノロンカルボン酸誘導体、その調製方法、組成物、および医薬としての使用
BRPI0409105A (pt) 2003-04-07 2006-04-25 Cylene Pharmaceuticals Inc análogos de quinobenzoxazina substituìdos
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
DE102005030524A1 (de) 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituierte Chinolone II

Also Published As

Publication number Publication date
CA2574464A1 (en) 2006-01-26
ES2296205T3 (es) 2008-04-16
US20070293478A1 (en) 2007-12-20
CA2574464C (en) 2013-02-12
EP1768973A1 (de) 2007-04-04
JP2008506737A (ja) 2008-03-06
CN101031557B (zh) 2011-07-27
CN101031557A (zh) 2007-09-05
DE502005002176D1 (de) 2008-01-17
WO2006008046A1 (de) 2006-01-26
US7867992B2 (en) 2011-01-11
ATE380188T1 (de) 2007-12-15
JP5068648B2 (ja) 2012-11-07
DE102004035203A1 (de) 2006-02-16
EP1768973B1 (de) 2007-12-05

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
HK1093729A1 (en) Substituted quinolones
JO2581B1 (en) Aryl sulfonomides replaced
UA102065C2 (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
TW200621765A (en) Substituted phenylaminothiazoles and their use
TW200736213A (en) Dicarboxylic acid derivatives and their use
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
ATE453642T1 (de) Substituierte phenylaminopyrimidine
TW200724532A (en) Pyrimidinecarboxylic acid derivatives and their use
WO2006089664A3 (de) Heterocyclylamid-substituierte imidazole
MY150931A (en) Substituted oxazolidinones and their use
WO2006023843A3 (en) Novel heterocycles
TW200726763A (en) Novel compound
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
TW200621799A (en) Acylated nonadepsipeptides II
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
IL187001A0 (en) Preparation of (s)-4-fluromethyl-dihydro-furan -2-one
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ATE455789T1 (de) Substituierte nonadepsipeptide
IL194353A0 (en) Lysobactin amides
MY151590A (en) Substituted quinolones iii
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ATE553088T1 (de) Substituierte chinolone ii
MX2008013477A (es) Compuestos biciclicos de tetrahidropirrol.